Carlos Rodriguez-Galindo
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Carlos Rodriguez-Galindo
Jun 6, 2024, 14:22 |
Blog
Felicia Marie Knaul: Report From the 2022/2023 Access to Essential Cancer Medicines Stakeholder Summit by Edward Briercheck
Felicia Marie Knaul, Director of the University of Miami Institute for Advanced Study of the…
May 22, 2024, 13:39 |
Blog
Cankids recently hosted the "One World: One Vision" webinar on May 16
Guillermo Chantada shared the following post by CanKids KidsCan on LinkedIn, adding the following: "It was…
Feb 19, 2024, 09:16 |
Blog
An invested group of researchers and patient advocates convened in Memphis for the first NACHO Consortium workshop - St. Baldrick’s Foundation
St. Baldrick’s Foundation made the following post on LinkedIn: ''Last week, an invested group of researchers…
Oct 19, 2023, 18:01 |
Blog
James R. Downing: The advancement of science and medicine requires creative thinking and collaboration
James R. Downing, President and Chief Executive Officer at St. Jude Children’s Research Hospital, shared…
Oct 17, 2023, 17:01 |
Blog
Eric Bouffet: Thank you for your contagious enthusiasm, Julia, and for your leadership and advocacy!
Eric Bouffet, Head of the Neuro-Oncology Section in the Division of Haematology/Oncology at The Hospital for Sick…
All:
5
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube